<?xml version="1.0" encoding="UTF-8"?>
<p id="p0200">Actually, this is a technique to vaccinate the host against the antigens of the tumour but, while dendritic cells (DCs) vaccines alone have shown a limited promise in the treatment of patients with advanced cancers, their combination with a potent recall antigen such as tetanus/diphtheria toxoid can significantly improve their efficacy, especially if pre-immunization exist 
 <xref rid="b0035" ref-type="bibr">[7]</xref>.
</p>
